
DBV Technologies S.A.
DBVTNASDAQHealthcare● Active
$16.00
$-0.59(-3.56%)
Market Cap$382747824
P/E Ratio—
52W High$26.185
52W Low$8.5
DBV Technologies S.A.(DBVT)· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · DBVT · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.19B | $0.03B | $0.14B | $0.21B | $0.08B |
| Net Receivables | $0.02B | $0.01B | $0.02B | $0.01B | $0.03B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $0.21B | $0.04B | $0.16B | $0.22B | $0.11B |
| PP&E Net | $0.01B | $0.02B | $0.02B | $0.02B | $0.02B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.23B | $0.07B | $0.18B | $0.25B | $0.15B |
| Liabilities | |||||
| Short-Term Debt | $0.02B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.04B | $0.02B | $0.02B | $0.01B | $0.01B |
| Total Current Liabilities | $0.06B | $0.03B | $0.04B | $0.03B | $0.03B |
| Long-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.06B | $0.04B | $0.04B | $0.05B | $0.05B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.39B) | ($0.29B) | ($0.24B) | ($0.26B) | ($0.10B) |
| Total Stockholders Equity | $0.17B | $0.03B | $0.14B | $0.19B | $0.10B |
| Total Liab & Equity(computed) | $0.23B | $0.07B | $0.18B | $0.25B | $0.15B |
| Debt Summary | |||||
| Total Debt | $0.02B | $0.01B | $0.01B | $0.00B | $0.01B |
| Net Debt | ($0.17B) | ($0.02B) | ($0.13B) | ($0.21B) | ($0.07B) |
数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · B
深入了解DBV Technologies S.A.
关于DBV Technologies S.A.(DBVT)资产负债表
DBV Technologies S.A.总资产$0.23B,现金及短期投资$0.19B,总负债$0.06B,总债务$0.02B,股东权益$0.17B。
常见问题
DBVT · 4 问DBV Technologies S.A.总债务$0.02B,净债务($0.17B)。
DBVT total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10